Clinical Trials Browser

Recurrence × Immunotherapy × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Recurrence

NCT06197776 2025-01-28

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Recruiting

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT02035358 2022-04-06

Immunotherapy Study for Metastatic Renal Cell Cancer

Phase 1 Completed

18 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

NCT04981665 2022-01-05

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Phase 2 Unknown

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT05059782 2021-09-28

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Phase NA Unknown

150 enrolled

Gynecologic

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

Clinical Trials

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Immunotherapy Study for Metastatic Renal Cell Cancer

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer